Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)
Mikkel Jürgens, Morten Schou, Philip Hasbak, Andreas Kjær, Emil Wolsk, Bo Zerahn, Mikkel Wiberg, Niels Høgh Brandt, Peter Haulund Gæde, Peter Rossing, Jens Faber, Silvio Inzucchi, Finn Gustafsson, Caroline Michaela Kistorp*
Research output: Contribution to journal › Journal article › Research › peer-review
57Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)'. Together they form a unique fingerprint.